2021
DOI: 10.1007/s12016-020-08829-y
|View full text |Cite
|
Sign up to set email alerts
|

The Roles of Orphan G Protein-Coupled Receptors in Autoimmune Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 189 publications
0
2
0
Order By: Relevance
“…The array of established GPCR ligands is as wide-ranging and rich as the physiological processes that they mediate, and these include odorants, gustatory molecules, ions, photons, protons, neurotransmitters, hormones, chemokines, lipids, pheromones, amino acids and their derivatives, peptides, nucleotides, small organic molecules (Bockaert, 1999;Civelli, 2001;Kroeze et al, 2003;Civelli et al, 2006) and microbial products such as short chain fatty acids and signal peptides (Brown et al, 2003). Despite the broad scope of GPCRs mediating physiological processes and their therapeutic relevance in OPEN ACCESS EDITED BY cancer, metabolic disorders, autoimmune diseases, and central nervous system (CNS) disorders, some remain as orphans for which no endogenous ligand(s) have been identified (Zhao et al, 2021). Orphan GPCRs account for ~30% of the ~400 non-olfactory human GPCRs (Laschet et al, 2018;Alexander et al, 2019) as illustrated in Figure 1.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The array of established GPCR ligands is as wide-ranging and rich as the physiological processes that they mediate, and these include odorants, gustatory molecules, ions, photons, protons, neurotransmitters, hormones, chemokines, lipids, pheromones, amino acids and their derivatives, peptides, nucleotides, small organic molecules (Bockaert, 1999;Civelli, 2001;Kroeze et al, 2003;Civelli et al, 2006) and microbial products such as short chain fatty acids and signal peptides (Brown et al, 2003). Despite the broad scope of GPCRs mediating physiological processes and their therapeutic relevance in OPEN ACCESS EDITED BY cancer, metabolic disorders, autoimmune diseases, and central nervous system (CNS) disorders, some remain as orphans for which no endogenous ligand(s) have been identified (Zhao et al, 2021). Orphan GPCRs account for ~30% of the ~400 non-olfactory human GPCRs (Laschet et al, 2018;Alexander et al, 2019) as illustrated in Figure 1.…”
Section: Introductionmentioning
confidence: 99%
“…Orphan GPCRs account for ~30% of the ~400 non-olfactory human GPCRs (Laschet et al, 2018;Alexander et al, 2019) as illustrated in Figure 1. The "non-sensory" GPCRs are targeted by over 40% of clinically administered drugs (Zhao et al, 2021). In a joint effort between the British Pharmacological Society and the International Union of Basic and Clinical Pharmacology (IUPHAR), a record of orphans and the extensive set of deorphanized GPCRs (Alexander et al, 2019) is archived in the Guide to Pharmacology database accessible at https:// www.guidetopharmacology.org/GRAC/ReceptorFamiliesForward?type= GPCR.…”
Section: Introductionmentioning
confidence: 99%